We serve Chemical Name:3,5-Dibromo-4-methoxybenzoic acid CAS:4073-35-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3,5-Dibromo-4-methoxybenzoic acid
CAS.NO:4073-35-2
Synonyms:3,5-dibromo-4-methoxybenzoic acid;MFCD00016511
Molecular Formula:C8H6Br2O3
Molecular Weight:309.93900
HS Code:2918990090
Physical and Chemical Properties:
Melting point:224 °C
Boiling point:365.2ºC at 760 mmHg
Density:1.957g/cm3
Index of Refraction:1.614
PSA:46.53000
Exact Mass:307.86800
LogP:2.91840
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 3,5-dibromo-4-methoxybenzoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD00016511 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3,5-dibromo-4-methoxybenzoic acid Use and application,3,5-dibromo-4-methoxybenzoic acid technical grade,usp/ep/jp grade.
Related News: On Friday, the Trump administration announced it will deny entry to foreign nationals who have traveled in China in the last 14 days, starting Sunday. 3,5-Dibromo-4-methoxybenzoic acid manufacturer Taking Teva as an example, it has 2 large R & D centers and 3 professional R & D centers in 5 countries, which effectively supports the development of Teva’s generic pharmaceutical sector. 3,5-Dibromo-4-methoxybenzoic acid supplier Taking Teva as an example, it has 2 large R & D centers and 3 professional R & D centers in 5 countries, which effectively supports the development of Teva’s generic pharmaceutical sector. 3,5-Dibromo-4-methoxybenzoic acid vendor Taking Teva as an example, it has 2 large R & D centers and 3 professional R & D centers in 5 countries, which effectively supports the development of Teva’s generic pharmaceutical sector. 3,5-Dibromo-4-methoxybenzoic acid factory Taking Teva as an example, it has 2 large R & D centers and 3 professional R & D centers in 5 countries, which effectively supports the development of Teva’s generic pharmaceutical sector.